Autism Spectrum Disorder Trial, Recruiting NCT06497218 Sponsor: Blinklab Limited Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT06497218
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children between the ages of 3 and 12 years old at the time of joining the trial.
  • A parent or caregiver who is able to read, understand, and sign the consent forms on behalf of the child.
  • Children with normal vision, or vision that is corrected to normal (for example, with glasses), good enough to watch short videos.
  • Children with hearing good enough to hear sounds played through headphones.

Who may not be able to join:

  • Children who are younger than 3 or older than 12 years old.
  • Children with severe hearing or vision impairment.
  • Children who are currently taking medications that affect the nervous system (a specific category of medicines known as ATC N0 medications — confirm with trial site if unsure whether a current medication falls into this category).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +31611132247

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Blinklab Limited
Registry
ClinicalTrials.gov
Start date
15 May 2023
Est. completion
16 October 2024

Where this trial is recruiting

Morocco

Primary endpoints

Device Sensitivity; Device Specificity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov